Why choose a PET scan?
PET scans are often chosen to help develop an informed treatment plan for prostate cancer because they provide important information.
First, an imaging agent–like POSLUMA–is injected into the body. Then, it binds to a target, such as cancer cells, to light it up. This can be seen on images from a PET scan, showing the location of the disease. Keep in mind that like all imaging agents, POSLUMA may not detect all prostate cancer. How do PET scans work?
How POSLUMA works
The surface of most prostate cancer cells has elevated levels of a protein called prostate-specific membrane antigen, or PSMA . As an advanced diagnostic imaging agent, POSLUMA is highly specific to PSMA and attaches to it, highlighting prostate cancer where it’s located.
As with all diagnostic imaging tests, it’s possible that physicians may interpret POSLUMA PET scan results incorrectly. This means that a negative POSLUMA PET scan does not confirm or rule out the presence of prostate cancer.
PET=positron emission tomography. SELECT IMPORTANT SAFETY INFORMATION
• P OSLUMA use contributes to a patient’s overall long-term cumulative radiation exposure. Long-term cumulative radiation exposure is associated with an increased risk for cancer. Advise patients to hydrate before and after administration and to void frequently after administration. Ensure safe
handling to minimize radiation exposure to the patient and health care providers.
Made with FlippingBook flipbook maker